Navigation Links
March of Dimes Awards $250,000 Prize to Scientists Who Explained Human Sex Chromosomes
Date:5/2/2011

DENVER, May 2, 2011 /PRNewswire-USNewswire/ -- Two scientists who pioneered research on the X and Y chromosomes have been chosen to receive the 2011 March of Dimes Prize in Developmental Biology.

Patricia Ann Jacobs, OBE, DSc, FRS, professor of Human Genetics, Southampton University Medical School and co-director of Research, Wessex Regional Genetics Laboratory, Salisbury, England and David C. Page, MD, director, Whitehead Institute, investigator of the Howard Hughes Medical Institute and professor of Biology at Massachusetts Institute of Technology, Cambridge, will share this year's prize.

Patricia Ann Jacobs was the first to describe a human sex chromosome abnormality with her landmark 1959 paper on Klinefelter syndrome, a disorder involving an additional X chromosome. 

David Page's studies of the Y chromosome revealed its role as a complex genetic system with many specialized functions, far beyond determining male sex.

"Taken together, the research  of Patricia Ann Jacobs and David Page has expanded medicine's ability to diagnose and understand the basis of infertility and many other diseases," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes.

The prize was presented today to Patricia Ann Jacobs and David Page at a gala black-tie dinner and ceremony held at the Four Seasons Hotel, here. They also delivered the Sixteenth Annual March of Dimes Prize Lecture at the Colorado Convention Center at the annual meeting of the Pediatric Academic Societies. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, hosted the award ceremony.

Individuals who receive the March of Dimes Prize are leaders in the field of developmental biology. Their pioneering research offers hope for prevention and treatments for some of the most serious birth defects and other human diseases.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects. The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk shortly before his death in 1995. Dr. Salk received Foundation support for his work to create a polio vaccine. The prize is a cash award of $250,000 and a silver medal in the design of the Roosevelt dime, in honor of President Franklin D. Roosevelt, who founded the March of Dimes.

In its 16-year history, the March of Dimes Prize in Developmental Biology has been the crowning glory of a distinguished research career or a stepping stone on the path toward future honors for researchers. In fact, five past March of Dimes Prize recipients have gone on to win a Nobel Prize®. 

The March of Dimes is the leading nonprofit organization for pregnancy and baby health.  With chapters nationwide and its premier event, March for Babies®, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit marchofdimes.com or nacersano.org.

The March for Babies is sponsored nationally by Kmart, Farmers Insurance Group, Bayer HealthCare, CIGNA, United Airlines, Famous Footwear, FedEx, Sanofi Pasteur, First Response, and Mission Pharmacal. To join an event near you, visit marchforbabies.org.


'/>"/>
SOURCE March of Dimes
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Tengion To Host Conference Call To Provide a Business Update and Report Fourth Quarter 2010 Financial Results on March 25, 2011
2. PharmAthene to Host Year-End 2010 Earnings Conference Call and Webcast on Monday, March 28, 2011
3. TPI Attends 23rd ROTH Annual OC Growth Stock Conference from March 13-16, 2011
4. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011
6. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
7. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
8. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
9. UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication
10. Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit on Tuesday, March 1
11. NeoStem to Present at Wall Street Forum 2011 Financial Conference on Tuesday, March 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... PARSIPPANY, N.J. , Feb. 24, 2017 /PRNewswire/ ... botanicals and biotechnology are now the fastest growing ... the Specialty Actives in Personal Care: Multi-regional ... market research and management consulting firm Kline. ... using bioprocesses that make them more effective for ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm Reports ... the laboratory use of nuclear magnetic resonance spectroscopy ... end-users and profiled current practices, developments, trends and ... well as growth and opportunities. These areas include ... NMR instruments, needs and innovation requirements, hyphenated NMR ...
(Date:1/23/2017)... 2017  The latest mobile market research from Acuity ... dramatically. The quarterly average price of a biometric smartphone ... Q4 2016.  There are now 120 sub-$150 models on ... from just 28 a year ago at an average ... Maxine Most , Acuity Market Intelligence Principal, "Biometric Smartphones ...
Breaking Biology News(10 mins):